The authors of this article discuss the development of alginate technology and its use within the management of exuding wounds and assess how ActivHeal Aquafiber® performs, and observe wound progression within standard care. A clinical market evaluation was conducted in two UK sites. The primary objective of the study was to observe the wound progression in terms of wound size and condition of the wound bed. The outcome of the evaluation demonstrated Activheal Aquafiber® effectively manages exudate, can assist in autolysis and improves peri-wound status.
